Please select the option that best describes you:

Topics: Breast Cancer • Medical Oncology • HER2+ • HR+ • Breast Cancer, Non-metastatic • Annals of Oncology Journal Club

How would you treat a patient with bilateral breast cancer, HER2 positive on one side and HER2 negative on the contralateral side, specifically in regards to adjuvant CDK4/6i vs neratinib?